Mexico is among the top 2 export destinations for 27 US states, a figure similar to that of the states (28) that count Mexico as one of their 3 main sources of imports.
The recent biotech innovations are most especially of this type, particularly the remarkable breadth of medical and pharmacological product development. One less welcome by-product of rapid economic and technological change that needs to be addressed is the insecurity felt by many workers. This stems, I suspect, from fear of job skill obsolescence.